Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.76M | 2.82M | 3.87M | 3.56M | 3.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.76M | 2.82M | 3.87M | 3.56M | 3.26M |
| Cost of Revenue | 264.10K | 1.23M | 2.21M | 2.83M | 3.48M |
| Gross Profit | 1.49M | 1.58M | 1.67M | 730.20K | -216.90K |
| SG&A Expenses | 1.73M | 3.15M | 4.58M | 5.69M | 6.83M |
| Depreciation & Amortization | 258.10K | 450.70K | 644.10K | 712.70K | 786.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.25M | 4.84M | 7.43M | 9.23M | 11.10M |
| Operating Income | -491.80K | -2.02M | -3.56M | -5.67M | -7.84M |
| Income Before Tax | -1.36M | -2.75M | -4.13M | -6.20M | -8.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.36 | -2.75 | -4.13 | -6.20 | -8.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.36M | -2.75M | -4.13M | -6.20M | -8.32M |
| EBIT | -491.80K | -2.02M | -3.56M | -5.67M | -7.84M |
| EBITDA | -182.70K | -1.53M | -2.92M | -4.96M | -7.05M |
| EPS Basic | -0.04 | -0.08 | -0.13 | -0.20 | -0.28 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.08 | -0.13 | -0.17 |
| EPS Diluted | -0.04 | -0.08 | -0.13 | -0.20 | -0.28 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.08 | -0.13 | -0.17 |
| Average Basic Shares Outstanding | 179.79M | 155.24M | 130.69M | 126.31M | 121.93M |
| Average Diluted Shares Outstanding | 179.79M | 155.24M | 130.69M | 126.31M | 121.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
